NASDAQ
Anixa Biosciences, Inc. (ANIX) has a free cash flow growth of -107.97% as of Friday, May 29, 2026. This represents a 190.60% decrease compared to its 12-month average of -37.15%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.